Detection of autoantibodies against oxidized low-density lipoproteins and of IgG-bound low density lipoproteins in patients with coronary artery disease
A Boullier, M Hamon, E Walters-Laporte… - Clinica chimica acta, 1995 - Elsevier
The role of oxidized low-density lipoprotein (ox-LDL) in the pathogenesis of atherosclerosis
has been the object of intense investigation. It has been proposed that, due to the antigenic …
has been the object of intense investigation. It has been proposed that, due to the antigenic …
Antibodies in action: the role of humoral immunity in the fight against atherosclerosis
JA Taylor, MA Hutchinson, PJ Gearhart, RW Maul - Immunity & Ageing, 2022 - Springer
The sequestering of oxidation-modified low-density lipoprotein by macrophages results in
the accumulation of fatty deposits within the walls of arteries. Necrosis of these cells causes …
the accumulation of fatty deposits within the walls of arteries. Necrosis of these cells causes …
Vaccines modulating lipoprotein autoimmunity as a possible future therapy for cardiovascular disease
J Nilsson, GN Fredrikson, H Björkbacka… - Journal of Internal …, 2009 - Wiley Online Library
Current strategies for prevention of cardiovascular disease focus on risk factor intervention.
Although these have been proven both safe and effective results from randomized clinical …
Although these have been proven both safe and effective results from randomized clinical …
Autoantibodies against oxidized low density lipoproteins in patients with stable angina, unstable angina or peripheral vascular disease; pathophysiological …
Background Antibody antioxidized low density lipoproteins (oxLDL) might play a role both in
atherogenesis and in the pathogenesis of acute coronary syndromes. Methods and Results …
atherogenesis and in the pathogenesis of acute coronary syndromes. Methods and Results …
Reduced in vivo aortic uptake of radiolabeled oxidation-specific antibodies reflects changes in plaque composition consistent with plaque stabilization
M Torzewski, PX Shaw, KR Han, B Shortal… - … , and vascular biology, 2004 - Am Heart Assoc
Objective—Labeled oxidation-specific antibodies (Ox-AB) detect, quantify, and
noninvasively image lipid-rich atherosclerotic lesions. However, it is unknown whether Ox …
noninvasively image lipid-rich atherosclerotic lesions. However, it is unknown whether Ox …
Specific autoantigens in experimental autoimmunity‐associated atherosclerosis
AJ Merched, D Daret, L Li, N Franzl… - The FASEB …, 2016 - Wiley Online Library
Higher cardiovascular morbidity in patients with a wide range of autoimmune diseases
highlights the importance of autoimmunity in promoting atherosclerosis. Our purpose was to …
highlights the importance of autoimmunity in promoting atherosclerosis. Our purpose was to …
Malondialdehyde epitopes as targets of immunity and the implications for atherosclerosis
N Papac-Milicevic, CJL Busch, CJ Binder - Advances in immunology, 2016 - Elsevier
Accumulating evidence suggests that oxidation-specific epitopes (OSEs) constitute a novel
class of damage-associated molecular patterns (DAMPs) generated during high oxidative …
class of damage-associated molecular patterns (DAMPs) generated during high oxidative …
Serum autoantibodies against human oxidized low-density lipoproteins are inversely associated with severity of coronary stenotic lesions calculated by Gensini score
J Che, G Li, W Wang, Q Li, H Liu, K Chen… - Cardiology …, 2011 - journals.viamedica.pl
Background: The relationship between autoantibodies against human oxidized low-density
lipoprotein (anti-oxLDL) and the progression of atherosclerotic diseases is unclear. This …
lipoprotein (anti-oxLDL) and the progression of atherosclerotic diseases is unclear. This …
Antibodies to malondialdehyde oxidized low-density lipoproteins predict long term cardiovascular mortality in high risk patients
G Maiolino, L Pedon, M Cesari, AC Frigo… - International journal of …, 2013 - Elsevier
Aims Antibodies to oxidized low-density lipoproteins (oxLDLAbs) are detectable in the
serum of patients with and without atherosclerosis, but it is unclear if they play a pathogenic …
serum of patients with and without atherosclerosis, but it is unclear if they play a pathogenic …
[HTML][HTML] The effect of HLA-DRB1* 04: 01 on a mouse model of atherosclerosis
G Blackler, J Akingbasote, E Cairns, C Howlett… - Journal of Translational …, 2023 - Elsevier
Objectives HLA-DRB1 is associated with an increased risk of cardiovascular disease in
patients with rheumatoid arthritis (RA). This study aimed to determine the effect of HLA …
patients with rheumatoid arthritis (RA). This study aimed to determine the effect of HLA …